Keyphrases
Glioma
100%
Zinc Finger E-box Binding Homeobox 1 (ZEB1)
100%
Platelet-derived Growth Factor Receptor (PDGFR)
100%
Epithelial-mesenchymal Transition
100%
SHP2
100%
Glioma Stem Cells
18%
Phosphoinositide 3-kinase (PI3K)
12%
Receptor Tyrosine Kinase
12%
Patient-derived
12%
Knockdown
12%
PDGF-AA
12%
Glioma Cell Lines
12%
Cell Culture
6%
Therapeutic Target
6%
Tumor Growth
6%
Xenograft
6%
Human Cancer
6%
Invasiveness
6%
Tumor Invasion
6%
Primary Brain Tumor
6%
Cell Migration
6%
Pharmacological Inhibitors
6%
Receptor Activation
6%
Overall Survival
6%
Low Expression
6%
Inducer
6%
Conventional Therapy
6%
Glioma Patients
6%
Stem Cell Proliferation
6%
Feedback Loop
6%
Drug Resistance mutations
6%
PTPN11
6%
Growth Factor Receptor Signaling
6%
Activated Platelets
6%
MiR-200
6%
Orthotopic Xenograft Model
6%
Cellular Alterations
6%
Signaling Effectors
6%
Medicine and Dentistry
Ganglioglioma
100%
Platelet Derived Growth Factor Receptor
100%
Mesenchymal-Epithelial Transition
100%
Glioma Stem Cell
20%
Xenograft
13%
Protein Tyrosine Kinase
13%
Phosphoinositide 3-Kinase
13%
Glioma Cell Line
13%
Brain Cancer
6%
Cancer
6%
Tumor Progression
6%
Cell Proliferation
6%
Overall Survival
6%
Thrombocyte Activation
6%
Tumor Invasion
6%
microRNA 200
6%
Cell Culture
6%
Cell Migration
6%
Protein Kinase B
6%
Biochemistry, Genetics and Molecular Biology
Mesenchymal-Epithelial Transition
100%
ZEB1
100%
Platelet-Derived Growth Factor Receptor
100%
Stem Cell
20%
PDGFA
13%
Receptor Tyrosine Kinase
13%
Phosphoinositide 3-Kinase
13%
Cell Migration
6%
PTPN11
6%
Cell Culture
6%
Overall Survival
6%
Cell Proliferation
6%
Thrombocyte Activation
6%
Tumor Progression
6%
Protein Kinase B
6%
Mir-200
6%
Neuroscience
Platelet-Derived Growth Factor Receptor
100%
ZEB1
100%
Epithelial Mesenchymal Transition
100%
Stem Cell
20%
Receptor Tyrosine Kinase
13%
Cell Line
13%
Phosphoinositide 3-Kinase
13%
Protein Kinase B
6%
Mir-200
6%
Cell Proliferation
6%
Cell Culture
6%
Cell Migration
6%
Intracranial Tumor
6%